Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
Introduction Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. Objectives F...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2022-06-01
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822011944/type/journal_article |
| _version_ | 1797616746934304768 |
|---|---|
| author | D. Nzamba Nzamba K. Benallel A. Kaddaf M. Gartoum M. Kadiri |
| author_facet | D. Nzamba Nzamba K. Benallel A. Kaddaf M. Gartoum M. Kadiri |
| author_sort | D. Nzamba Nzamba |
| collection | DOAJ |
| description |
Introduction
Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms.
Objectives
Faire le point sur les modalités de prise en charge des symptômes psychotiques au cours de la maladie de Parkinson
Methods
Nous décrivons 3 cas de développement de symptômes psychotiques, survenus chez des patients atteints de la maladie de Parkinson, et faisons le point sur la prise en charge des manifestations symptomatiques psychiatriques dans la maladie de Parkinson, par une brève revue de la littérature.
Results
Case 1: 42-year-old man, with 5 years’ history of PD, presented with auditory hallucinations comorbid with paranoid personality disorder, which occurred 12 months following antiparkinsonian drugs use. Case 2: 58-year-old man, with 17 years’ history of PD, presented jealousy delusions and behavioral disorders, which occurred 12 years following antiparkinsonian drugs use. Case 3: 76-year-old man, with 36 years’ history of PD, presented visual hallucinations, subjective sensation of a presence and jealousy delusion, which occurred 26 years following antiparkinsonian drugs use.
Conclusions
Les symptômes psychotiques de la maladie de Parkinson sont fréquents. La prise en charge consiste à traiter les symptômes psychotiques sans aggraver les symptômes moteurs liés à l’hypo-dopaminergie.
Disclosure
No significant relationships.
|
| first_indexed | 2024-03-11T07:45:39Z |
| format | Article |
| id | doaj.art-d48aba14cb2042a094d47d4aadf59f2f |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:45:39Z |
| publishDate | 2022-06-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-d48aba14cb2042a094d47d4aadf59f2f2023-11-17T05:07:44ZengCambridge University PressEuropean Psychiatry0924-93381778-35852022-06-0165S470S47010.1192/j.eurpsy.2022.1194Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic AspectsD. Nzamba Nzamba0K. Benallel1A. Kaddaf2M. Gartoum3M. Kadiri4Military Teaching Hospital Mohammed V-Rabat, Department Of Psychiatry, Rabat, MoroccoMilitary Teaching Hospital Mohammed V-Rabat, Department Of Psychiatry, Rabat, MoroccoMilitary Teaching Hospital Mohammed V-Rabat, Department Of Psychiatry, Rabat, MoroccoMilitary Teaching Hospital Mohammed V-Rabat, Department Of Psychiatry, Rabat, MoroccoMilitary Teaching Hospital Mohammed V-Rabat, Department Of Psychiatry, Rabat, Morocco Introduction Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. Objectives Faire le point sur les modalités de prise en charge des symptômes psychotiques au cours de la maladie de Parkinson Methods Nous décrivons 3 cas de développement de symptômes psychotiques, survenus chez des patients atteints de la maladie de Parkinson, et faisons le point sur la prise en charge des manifestations symptomatiques psychiatriques dans la maladie de Parkinson, par une brève revue de la littérature. Results Case 1: 42-year-old man, with 5 years’ history of PD, presented with auditory hallucinations comorbid with paranoid personality disorder, which occurred 12 months following antiparkinsonian drugs use. Case 2: 58-year-old man, with 17 years’ history of PD, presented jealousy delusions and behavioral disorders, which occurred 12 years following antiparkinsonian drugs use. Case 3: 76-year-old man, with 36 years’ history of PD, presented visual hallucinations, subjective sensation of a presence and jealousy delusion, which occurred 26 years following antiparkinsonian drugs use. Conclusions Les symptômes psychotiques de la maladie de Parkinson sont fréquents. La prise en charge consiste à traiter les symptômes psychotiques sans aggraver les symptômes moteurs liés à l’hypo-dopaminergie. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S0924933822011944/type/journal_articlePsychosisTherapeuticParkinson’s disease |
| spellingShingle | D. Nzamba Nzamba K. Benallel A. Kaddaf M. Gartoum M. Kadiri Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects European Psychiatry Psychosis Therapeutic Parkinson’s disease |
| title | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
| title_full | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
| title_fullStr | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
| title_full_unstemmed | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
| title_short | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
| title_sort | psychotic symptoms and parkinson s disease clinical and therapeutic aspects |
| topic | Psychosis Therapeutic Parkinson’s disease |
| url | https://www.cambridge.org/core/product/identifier/S0924933822011944/type/journal_article |
| work_keys_str_mv | AT dnzambanzamba psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT kbenallel psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT akaddaf psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT mgartoum psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT mkadiri psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects |